Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Discovery Life Sciences Acquires Contract Research Firm In Vitro ADMET Laboratories
Maryland-based IVAL offers physiologically relevant in vitro experimental systems for drug metabolism, toxicology, and pharmacology testing.
The expansion is one of several updates on the DNA synthesis firm's plans for its fiscal year 2022, which began last month.
Twist Bioscience Reports 17 Percent Growth of Fiscal Q4 Revenues, to Acquire Abveris
The firm has entered into a definitive agreement to acquire Abveris, an antibody discovery company, for up to $190 million in stock and cash.
Investigators from the hospital's D3b program are leading development of what aims to be the largest clinically annotated pediatric brain tumor cohort study to date.
The firm outlined the ways it continues to diversify its core business while expanding both its headcount and footprint.